TRPC6 gene variants and neuropsychiatric lupus

Giuseppe A. Ramirez, Chiara Lanzani, Enrica P. Bozzolo, Lorena Citterio, Laura Zagato, Nunzia Casamassima, Valentina Canti, Maria Grazia Sabbadini, Patrizia Rovere-Querini, Paolo Manunta, Angelo A. Manfredi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Neuropsychiatric manifestations of systemic lupus erythematosus (NPSLE) influence patients' quality of life and their survival. Little is known about the pathophysiological bases of NPSLE and accordingly there are no specific therapeutic agents to be employed in this setting. Genetic research in systemic lupus erythematosus (SLE) is rapidly evolving as a tool to find clues about the pathogenic determinants of the disease and of its manifestations. Here, we describe the association of a single nucleotide polymorphic variant of the transient receptor potential cation channel, subfamily C, member 6 (TRPC6) gene with protection from the development of NPSLE in a cohort of 106 patients with SLE. TRPC6 is involved in the regulation of N-methyl-D-aspartate (NMDA) receptor signalling, a major player in post-ischemic neuronal injury and in the pathogenesis of NPSLE. TRPC6 genetic variants are promising candidate predictors of nervous system involvement in SLE, whereas the TRPC6 pathway might constitute a potential novel therapeutic target.

Original languageEnglish
Pages (from-to)21-24
Number of pages4
JournalJournal of Neuroimmunology
Volume288
DOIs
Publication statusPublished - Nov 15 2015

Fingerprint

Central Nervous System Lupus Vasculitis
Systemic Lupus Erythematosus
Genes
Transient Receptor Potential Channels
Genetic Research
N-Methyl-D-Aspartate Receptors
Nervous System
Nucleotides
Quality of Life
Survival
Wounds and Injuries
Therapeutics

Keywords

  • Genetics
  • Lupus
  • Neuropsychiatric involvement
  • TRPC6

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Cite this

TRPC6 gene variants and neuropsychiatric lupus. / Ramirez, Giuseppe A.; Lanzani, Chiara; Bozzolo, Enrica P.; Citterio, Lorena; Zagato, Laura; Casamassima, Nunzia; Canti, Valentina; Sabbadini, Maria Grazia; Rovere-Querini, Patrizia; Manunta, Paolo; Manfredi, Angelo A.

In: Journal of Neuroimmunology, Vol. 288, 15.11.2015, p. 21-24.

Research output: Contribution to journalArticle

Ramirez, Giuseppe A. ; Lanzani, Chiara ; Bozzolo, Enrica P. ; Citterio, Lorena ; Zagato, Laura ; Casamassima, Nunzia ; Canti, Valentina ; Sabbadini, Maria Grazia ; Rovere-Querini, Patrizia ; Manunta, Paolo ; Manfredi, Angelo A. / TRPC6 gene variants and neuropsychiatric lupus. In: Journal of Neuroimmunology. 2015 ; Vol. 288. pp. 21-24.
@article{f5e9fbbb26da47b0b76e997041cc2c1a,
title = "TRPC6 gene variants and neuropsychiatric lupus",
abstract = "Neuropsychiatric manifestations of systemic lupus erythematosus (NPSLE) influence patients' quality of life and their survival. Little is known about the pathophysiological bases of NPSLE and accordingly there are no specific therapeutic agents to be employed in this setting. Genetic research in systemic lupus erythematosus (SLE) is rapidly evolving as a tool to find clues about the pathogenic determinants of the disease and of its manifestations. Here, we describe the association of a single nucleotide polymorphic variant of the transient receptor potential cation channel, subfamily C, member 6 (TRPC6) gene with protection from the development of NPSLE in a cohort of 106 patients with SLE. TRPC6 is involved in the regulation of N-methyl-D-aspartate (NMDA) receptor signalling, a major player in post-ischemic neuronal injury and in the pathogenesis of NPSLE. TRPC6 genetic variants are promising candidate predictors of nervous system involvement in SLE, whereas the TRPC6 pathway might constitute a potential novel therapeutic target.",
keywords = "Genetics, Lupus, Neuropsychiatric involvement, TRPC6",
author = "Ramirez, {Giuseppe A.} and Chiara Lanzani and Bozzolo, {Enrica P.} and Lorena Citterio and Laura Zagato and Nunzia Casamassima and Valentina Canti and Sabbadini, {Maria Grazia} and Patrizia Rovere-Querini and Paolo Manunta and Manfredi, {Angelo A.}",
year = "2015",
month = "11",
day = "15",
doi = "10.1016/j.jneuroim.2015.08.015",
language = "English",
volume = "288",
pages = "21--24",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier Science B.V.",

}

TY - JOUR

T1 - TRPC6 gene variants and neuropsychiatric lupus

AU - Ramirez, Giuseppe A.

AU - Lanzani, Chiara

AU - Bozzolo, Enrica P.

AU - Citterio, Lorena

AU - Zagato, Laura

AU - Casamassima, Nunzia

AU - Canti, Valentina

AU - Sabbadini, Maria Grazia

AU - Rovere-Querini, Patrizia

AU - Manunta, Paolo

AU - Manfredi, Angelo A.

PY - 2015/11/15

Y1 - 2015/11/15

N2 - Neuropsychiatric manifestations of systemic lupus erythematosus (NPSLE) influence patients' quality of life and their survival. Little is known about the pathophysiological bases of NPSLE and accordingly there are no specific therapeutic agents to be employed in this setting. Genetic research in systemic lupus erythematosus (SLE) is rapidly evolving as a tool to find clues about the pathogenic determinants of the disease and of its manifestations. Here, we describe the association of a single nucleotide polymorphic variant of the transient receptor potential cation channel, subfamily C, member 6 (TRPC6) gene with protection from the development of NPSLE in a cohort of 106 patients with SLE. TRPC6 is involved in the regulation of N-methyl-D-aspartate (NMDA) receptor signalling, a major player in post-ischemic neuronal injury and in the pathogenesis of NPSLE. TRPC6 genetic variants are promising candidate predictors of nervous system involvement in SLE, whereas the TRPC6 pathway might constitute a potential novel therapeutic target.

AB - Neuropsychiatric manifestations of systemic lupus erythematosus (NPSLE) influence patients' quality of life and their survival. Little is known about the pathophysiological bases of NPSLE and accordingly there are no specific therapeutic agents to be employed in this setting. Genetic research in systemic lupus erythematosus (SLE) is rapidly evolving as a tool to find clues about the pathogenic determinants of the disease and of its manifestations. Here, we describe the association of a single nucleotide polymorphic variant of the transient receptor potential cation channel, subfamily C, member 6 (TRPC6) gene with protection from the development of NPSLE in a cohort of 106 patients with SLE. TRPC6 is involved in the regulation of N-methyl-D-aspartate (NMDA) receptor signalling, a major player in post-ischemic neuronal injury and in the pathogenesis of NPSLE. TRPC6 genetic variants are promising candidate predictors of nervous system involvement in SLE, whereas the TRPC6 pathway might constitute a potential novel therapeutic target.

KW - Genetics

KW - Lupus

KW - Neuropsychiatric involvement

KW - TRPC6

UR - http://www.scopus.com/inward/record.url?scp=84945538070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945538070&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2015.08.015

DO - 10.1016/j.jneuroim.2015.08.015

M3 - Article

C2 - 26531690

AN - SCOPUS:84945538070

VL - 288

SP - 21

EP - 24

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

ER -